Cargando…
Illness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1)
Rett Syndrome (RTT) is a severe neurodevelopmental disorder characterized by an apparently normal development followed by an arrest and subsequent regression of cognitive and psychomotor abilities. At present, RTT has no definitive cure and the treatment of RTT represents a largely unmet clinical ne...
Autores principales: | Pini, Giorgio, Congiu, Laura, Benincasa, Alberto, DiMarco, Pietro, Bigoni, Stefania, Dyer, Adam H., Mortimer, Niall, Della-Chiesa, Andrea, O'Leary, Sean, McNamara, Rachel, Mitchell, Kevin J., Gill, Michael, Tropea, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746298/ https://www.ncbi.nlm.nih.gov/pubmed/26925263 http://dx.doi.org/10.1155/2016/5073078 |
Ejemplares similares
-
IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients
por: Pini, Giorgio, et al.
Publicado: (2012) -
Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
por: Shovlin, Stephen, et al.
Publicado: (2022) -
Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome
por: O'Leary, Heather M., et al.
Publicado: (2018) -
Clinical and genetic Rett syndrome variants are defined by stable electrophysiological profiles
por: Keogh, Conor, et al.
Publicado: (2018) -
Repeated Insulin-Like Growth Factor 1 Treatment in a Patient with Rett Syndrome: A Single Case Study
por: Pini, Giorgio, et al.
Publicado: (2014)